Trial Profile

The (Norwegian) NOR Solidarity Multicenter Trial on the Efficacy of Different Anti-viral Drugs in SARS-CoV-2 Infected Patients

Status: Recruiting

Phase of Trial: Phase II/III

Latest Information Update: 06 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Sep 2024 Results (n=160) assessing the association between oropharyngeal viral load and inflammatory markers at hospital admission and during hospitalization and the ability of these biomarkers to predict the development of respiratory failure (RF) and theneed for ICU treatment during the first 10 days of hospitalizationpublished in the Journal of Internal Medicine
13 Jul 2021 Results (n=185) published in the Annals of Internal Medicine
15 Jan 2021 This trial has been discontinued in Sweden, according to European Clinical Trials Database record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com